Polaryx Therapeutics, Inc.
- Ticker
- PLYX
- CIK
- 2075320
- Industry
- Pharmaceutical Preparations
Financials 4
News 5
Ownership 9
- 4 Statement of changes in beneficial ownership of securities
- 4 Statement of changes in beneficial ownership of securities
- 3 Initial statement of beneficial ownership of securities
- 3 Initial statement of beneficial ownership of securities
- 3 Initial statement of beneficial ownership of securities
- 3 Initial statement of beneficial ownership of securities
- 3 Initial statement of beneficial ownership of securities
- 3 Initial statement of beneficial ownership of securities
- 3 Initial statement of beneficial ownership of securities
Prospectus 7
- S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
- 424B4 Prospectus filed pursuant to Rule 424(b)(4)
- S-1/A General form of registration statement for all companies including face-amount certificate companies
- S-1/A General form of registration statement for all companies including face-amount certificate companies
- S-1 General form of registration statement for all companies including face-amount certificate companies
- DRS/A Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
- DRS Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Proxies 2
- DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
- DEF 14A Definitive proxy statements
Other 9
- ARS Annual report to security holders
- SCHEDULE 13D
- EFFECT Notice of Effectiveness
- CERT Certification by an exchange approving securities for listing
- 8-A12B Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b)
- C-U Progress Update
- C-U Progress Update
- C/A Offering Statement
- C Offering Statement